Company Profile  


Status: Public   Founded:   SEC Filings: Below
Exchange: NASDAQ      Year End: n/a
Symbol: GNBT   Website:               

About Generex Biotechnology Corporation

Generex Biotechnology Corporation engages in the research and development of drug delivery systems and technology. Its products include morphine, fentanyl, heparin, and flu vaccine, which are used medically for pain relief and as a sedative. The company also offers Oralin product, which is a proprietary insulin formulation used for diabetes management. Its Oralin product is delivered through RapidMist device, which is used to administer large molecule drugs, including proteins, peptides, monoclonal antibodies, hormones, and vaccines. The company, through its subsidiary, Antigen Express, Inc., conducts research and development of technologies and immunomedicines for the treatment of malignant, infectious, autoimmune, and allergic diseases. Generex Biotechnology was founded in 1983 and is based in Ontario, Canada.

Generex Biotechnology Corporation


Media Files  

Audio Commentary Coming Soon


Media Center Items (Hi-Res Media Files):

Media Center


NAMC Newswire Items:

 All News

Click for Company Audio Files:

Click for Company Video Files:

Video Files

Click for Company News Feed

RSS Feed Add Feed To My Yahoo Add Feed  to My MSN


NAMC Latest  News NAMC Radio Podcast Wall Street to Main Street